The aim of this study was to investigate whether there was a significant difference in high-level aminoglycoside resistance (HLAR) between vancomycin-sensitive enterococci (VSE) and vancomycin-resistant enterococci (VRE). Vancomycin resistance was determined in 116 Enterococcus isolates using brain-heart infusion agar containing 6 μg/ml vancomycin. HLAR was determined by both standard agar screening and disk diffusion methods. Streptomycin and gentamicin were used as predictors of HLAR. Vancomycin resistance and HLAR were found in 17 (14.7%) and 41 (35.3%) of the Enterococcus strains, respectively. HLAR was found in 11 of 17 VRE and 30 of 98 VSE strains. HLAR in VRE strains was significantly higher than in VSE. More enterococcal strains were found to be resistant to both gentamicin and streptomycin (29) than to gentamicin (one) or streptomycin (11) alone. The HLAR rate in VRE was two-fold higher than in VSE. The synergistic bactericidal effect of aminoglycosides and β-lactam or glycopeptide antibiotics is lost if there is high-level resistance to aminoglycosides.
RobertCMoelleringJR: Enterococcus species, Streptococcus bovis and Leuconostoc species. In: Principles and Practice of Infectious Diseases, 5th edn (MandellGLDouglasRGBennettJE, eds). Philadelphia: Churchill Livingstone, 2000; pp2147–2166
2.
LowDEWilleyBMBetschelSKreiswirthB: Enterococcus: pathogens of the 90s. Eur J Surg Suppl1994; 573: 19–24
3.
FacklamRRSahmDFTeixeiraLM: Enterococcus. In: Manual of Clinical Microbiology, 7th edn (MurrayPRBaronEJPfallerMATenoverFCYolkenRH, eds). Washington DC: ASM Press, 1999; pp297–305
4.
HuyckeMMSahmDFGilmoreMS: Multiple drug resistant enterococci. The nature of the problem and an agenda for the future. Emerg Infect Dis1998; 4: 239–249
5.
ZouainMGArajGF: Antimicrobial resistance of Enterococci in Lebanon. Int J Antimicrob Agents2001; 17: 209–213
6.
SimjeeSManzoorSEFraiseAPGillMJ: Nature of transposon-mediated high-level gentamicin resistance in Enterococcus faecalis isolated in the United Kingdom. J Antimicrob Chemother2000; 45: 565–575
7.
National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing; Eleventh Informational Supplement. NCCLS Document M100-S11.Wayne, PA: NCCLS, 2001
SwensonJMHindlerJAPetersonLR: Special phenotypic methods for detecting antibacterial resistance. In: Manual of Clinical Microbiology, 7th edn (MurrayPRBaronEJPfallerMATenoverFCYolkenRH, eds). Washington, DC; ASM Press, 1999; pp1563–1577
10.
CirakMYSultanN: Prevalence of high level aminoglycoside and vancomycin resistance among enterococci in Turkey. Acta Microbiol Pol1998; 47: 267–273
11.
GordtsBvan LanduytHIevenMvan DammePGoossensH: Vancomycin-resistant enterococci colonising the intestinal tracts of hospitalized patient. J Clin Microbiol1995; 33: 2842–2846
12.
ArthurMReynoldsPCourvalinP: Glycopeptide resistance in enterococci. Trends Microbiol1996; 4: 401–407
13.
LaveryARossneyASMorrisonDPowerAKeaneCT: Incidence and detection of multidrug resistant enterococci in Dublin hospitals. J Med Microbiol1997; 46: 150–156
14.
MarcusNPeletNYagupskyP: Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in Southern Israel. Eur J Clin Microbiol Infect Dis1997; 16: 913–915
15.
EliopoulosGMWennerstenCBGoldHSSchulinTSouliMFarrisMG: Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Antimicrob Agents Chemother1998; 42: 1088–1092
16.
LiassineNFreiRJanIAuckenthalerR: Characterization of glycopeptide-resistant enterococci from a Swiss hospital. J Clin Microbiol1998; 36: 1853–1858
17.
TornieporthNGRobertsRBJohnJHafnerARileyLW: Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis1996; 23: 767–772
18.
SwensonJMClarkNCSahmDFFerraroMJDoernGHindlerJ: Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol1995; 33: 3019–3021
19.
SchoutenMAHoogkamp-KorstanjeJAMeisJFVossA: Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis2000; 19: 816–822
20.
ScagnelliMPellizerGde LallaFD'EmilioARassuMBragagnoloL: Epidemiological analysis of vancomycin-resistant enterococci in a large tertiary-care hospital in Northern Italy. Eur J Clin Microbiol Infect Dis2001; 20: 609–616
21.
BhatKGPaulCBhatMG: High level aminoglycoside resistance in enterococci isolated from hospitalized patients. Indian J Med Res1997; 105: 198–199
22.
JohnsonAPWarnerMHallasGLivermoreDM: Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999. J Antimicrob Chemother2000; 46: 125–128
23.
OzkuyumcuC: Resistant enterococci: prevalence and factors associated with colonization in a Turkish university hospital. Acta Microbiol Pol1999; 48: 203–207
